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1. INTRODUCTION {#ccr32819-sec-0001}
===============

The subcutaneous implantable cardioverter defibrillator (S‐ICD; Boston Scientific) is a safe and effective implantable defibrillator option for the prevention of sudden cardiac death (SCD).[^1^](#ccr32819-bib-0001){ref-type="ref"} Implant technique and location of the generator and electrode are critical to ensure appropriate sensing, defibrillation threshold (DFT), and reduction of long‐term system complication rates.[^2^](#ccr32819-bib-0002){ref-type="ref"}, [^3^](#ccr32819-bib-0003){ref-type="ref"} This report highlights the advantages of the intermuscular S‐ICD implant technique and the importance of this procedure as an option in the event of inappropriate shocks due to generator placement.

2. METHODS {#ccr32819-sec-0002}
==========

A 57‐year‐old female patient with a history of cardiomyopathy received a S‐ICD model 1010 device implant in April 2014. At the time of implant, the device was programmed to Secondary vector for sensing (distal electrode---Can). During the preimplant screening process, the patient passed screening in Secondary and Primary vectors, but failed in Alternate due to a poor QRS:T‐wave ratio. Defibrillation testing was performed at implant with a successful 65J DFT and recorded shock impedance of 125 ohms. Three years post‐op, she presented to the office for routine follow‐up and was unaware that she received an inappropriate shock from her S‐ICD. This was the first episode noted on her device since implant. Upon evaluation, it was determined she had received a shock due to T‐wave oversensing while programmed to Secondary vector. During the episode, the QRS:T‐wave ratio appeared degraded when compared to the manually captured Secondary subcutaneous electrocardiogram (S‐ECG). After evaluation of the sensing vectors, the device was programmed to Primary vector (xyphoid electrode---Can) which had an appropriate QRS:T‐wave ratio.

The following month the patient presented to the office with three inappropriate shocks from the S‐ICD. It was determined that the patient had received inappropriate shocks for oversensing of T‐waves while programmed to Primary vector (Figure [1](#ccr32819-fig-0001){ref-type="fig"}). The cause of the T‐wave oversensing was attributed to a degradation of the QRS amplitude. All inappropriate shocks occurred while the patient was lying down, primarily on the left side. The patient was further evaluated while performing postural changes, and it was noted that the QRS amplitude varied in real time with these changes to posture (Figure [2](#ccr32819-fig-0002){ref-type="fig"}). Pocket evaluation was performed, and it was found that the device was in an anterior position, most likely in adipose tissue; and the device tended to migrate with postural changes causing variances in the QRS amplitude. The S‐ICD generator is an integral part of the sensing vector when programmed to Primary or Secondary vector. Alternate vector (distal electrode--xyphoid electrode) was not a programming option due to a poor QRS:T‐wave ratio.

![Shock in Primary vector due to T‐wave oversensing and QRS amplitude degradation](CCR3-8-1081-g001){#ccr32819-fig-0001}

![Primary vector S‐ECG showing QRS amplitude degradation with postural changes](CCR3-8-1081-g002){#ccr32819-fig-0002}

X‐ray images were obtained and compared to the images from implant (Figure [3](#ccr32819-fig-0003){ref-type="fig"}A,B), and it was confirmed that the device had been inappropriately placed in an anterior axillary position at implant and that the generator appeared to have slightly migrated in the pocket. (Figure [3](#ccr32819-fig-0003){ref-type="fig"}C,D) Although the device was sutured to the fascia at implant, it was decided that the sutures were most likely no longer intact and holding the generator in a secured position. After discussing the case details, the decision was made to reposition the generator to the intermuscular pocket as recommended in labeling by Boston Scientific.[^4^](#ccr32819-bib-0004){ref-type="ref"}

![Chest x‐ray images: A, lateral at implant, B, posteroanterior (PA) at implant, C, lateral post‐shock, D, PA post‐shock, E, lateral pocket revision, and F, anteroposterior (AP) pocket revision](CCR3-8-1081-g003){#ccr32819-fig-0003}

The patient was admitted to the hospital in October 2017 to undergo generator pocket revision. Anesthesia evaluated the patient and induced standard general anesthesia. Marking lines were placed on the patient after fluoroscopy‐guided images were obtained to verify appropriate generator placement posterior to the midaxillary line. The patient was prepped and draped in sterile surgical fashion. The generator was extracted in routine manner at this point with a new 4‐cm incision placed on the left lateral aspect, 4 finger breadths above the latissimus dorsi muscle. Electrocautery was used to dissect the pocket and obtain hemostasis. The incision was deepened through the subcutaneous layers down to the rib cage. In the avascular plane, we were able to create the intermuscular pocket between the serratus anterior and latissimus dorsi using blunt dissection without any significant bleeding.[^5^](#ccr32819-bib-0005){ref-type="ref"} After positioning the generator in the intermuscular pocket, the device was secured per instructions for use and successful defibrillation testing was performed with a threshold of 80J. The surgical wound was closed in a multi‐layer fashion with a sterile dressing applied upon closure. The patient was taken to recovery without any adverse events.

3. RESULTS {#ccr32819-sec-0003}
==========

Postoperative images confirm the generator was appropriately repositioned posterior to the midaxillary line (Figure [3](#ccr32819-fig-0003){ref-type="fig"}E,F). Postoperative device interrogation showed no changes to the QRS morphology with postural variation or while the patient was in the left lateral recumbent position with the device secured in the intermuscular pocket. There have been no episodes of oversensing or inappropriate shocks after the device was placed in the intermuscular position.

4. DISCUSSION {#ccr32819-sec-0004}
=============

In the event of inappropriate shocks with degradation of QRS amplitude, it is important to not only evaluate the captured S‐ECG's in one position, but in various positions, especially that in which the patient received therapy. Changes in posture can result in QRS degradation leading to oversensing of T‐waves as the sensing algorithm adjusts to detect the low‐amplitude QRS signal. It is critical to recognize the role the generator plays in appropriate sensing and ensure at implant that the device is placed in an appropriate midaxillary to posterior axillary position and secured to avoid migration. The sensing vector is not constant if the device is not attached immediately to the chest wall fascia; and when placed in the soft tissue component of the chest wall, namely subcutaneous adipose, it creates the possibility of postural variations, that is, undulating vectors, which can lead to inappropriate therapy.

Another point to note is that the device in its original positioning recorded elevated shock impedances for each of the inappropriate shocks, ranging from 188 to 199 ohms. Data presented in 2018 indicates that impedances greater than 110 ohms have notably lower success rates at 65 Joules and may warrant evaluation of the full system placement, including both the generator and the coil.[^6^](#ccr32819-bib-0006){ref-type="ref"} At the time of this revision in 2017, the shock impedance decreased by roughly 30%, registering at 137 ohms during DFT testing, with the first shock failing at 65J followed by a successful 80J shock. The successful 80J DFT is considered safe and appropriate so the coil position was not revised. Based on this new data showing an inverse relationship between shock impedance and DFT conversion success, along with demonstrating that increased subcutaneous fat underneath either the coil or the generator impairs system success, we would have also revised the coil depth to ensure DFT efficacy. With evaluation of the X‐ray images, there is a clinically significant amount of subcoil fat that contributed to the elevated shock impedance and failure to convert at 65J even after revision of the generator placement.

5. CONCLUSION {#ccr32819-sec-0005}
=============

It has been our experience that placing the generator in an intermuscular position between the serratus anterior and latissimus dorsi appears to be a superior approach to the subcutaneous implant both in terms of DFT efficacy and long‐term patient comfort. The intermuscular implant protects against migration of the device during postural changes, especially in patients with increased body mass index. Through other studies, the intermuscular technique has been shown to be a safe and effective alternative approach to the S‐ICD implant while providing low complications rates, appropriate sensing vectors, effective and possibly improved defibrillation thresholds, and better cosmetic outcomes.[^5^](#ccr32819-bib-0005){ref-type="ref"}, [^7^](#ccr32819-bib-0007){ref-type="ref"}, [^8^](#ccr32819-bib-0008){ref-type="ref"} In the event of inappropriate therapy with a S‐ICD, evaluation of alternative sensing vector S‐ECGs should take place while the patient is placed in multiple postural variations as well as consideration given to the evaluation of the full system placement to rule out the possibility of device or coil migration.
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